Dr. Maral Baghai Arassi, Germany
Association of intraindividual tacrolimus variability and concentration-to-dose ratio with allograft rejection in pediatric kidney transplant recipients

Mrs. Lynn Maestretti, United States
Evaluating the Risk and Benefit of Once Daily Mycophenolate Acid in Pediatric Kidney Transplant Recipients

Mr. David Nehl, Germany
Immune Monitoring by Torque-Teno Virus Load in Addition to Virus-Specific T Cells After Pediatric Kidney Transplantation

Dr. Katherine D Westreich, United States
Outcomes after basiliximab, thymoglobulin, or alemtuzumab induction for pediatric kidney transplant: A single center study

Mr. Martin Jaros, Germany
Insights into the Interplay between Senescent Cells and Immune Cells in the Kidney Microenvironment

Ms. Anna Quarder, Germany
Sex differences in endothelial cell senescence are independent of gonadal-hormones

Dr. Sandra Amaral, United States
Evaluating Feasibility and Clinical Relevance of Pharmacogenomic Testing using Whole Genome Sequencing in Pediatric Kidney Transplantation

Ms. Sierra Scodellaro, Canada
Pharmacogenetics in pediatric kidney transplant: Leveraging CYP3A5-guided therapy for improved patient outcomes